ES2282446T3 - Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih). - Google Patents

Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih). Download PDF

Info

Publication number
ES2282446T3
ES2282446T3 ES02758207T ES02758207T ES2282446T3 ES 2282446 T3 ES2282446 T3 ES 2282446T3 ES 02758207 T ES02758207 T ES 02758207T ES 02758207 T ES02758207 T ES 02758207T ES 2282446 T3 ES2282446 T3 ES 2282446T3
Authority
ES
Spain
Prior art keywords
methyl
substituted
alkyl
isopropyl
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02758207T
Other languages
English (en)
Spanish (es)
Inventor
Brian William Dymock
Adrian Liam Gill
Philip Stephen Jones
Kevin Edward Burdon Parkes
Martin John Parratt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2282446T3 publication Critical patent/ES2282446T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
ES02758207T 2001-06-04 2002-05-29 Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih). Expired - Lifetime ES2282446T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0113524 2001-06-04
GBGB0113524.3A GB0113524D0 (en) 2001-06-04 2001-06-04 Pyrazole derivatives

Publications (1)

Publication Number Publication Date
ES2282446T3 true ES2282446T3 (es) 2007-10-16

Family

ID=9915841

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02758207T Expired - Lifetime ES2282446T3 (es) 2001-06-04 2002-05-29 Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih).

Country Status (17)

Country Link
US (1) US6538015B1 (https=)
EP (1) EP1401826B1 (https=)
JP (1) JP4088249B2 (https=)
KR (1) KR100627532B1 (https=)
CN (1) CN1249052C (https=)
AT (1) ATE357439T1 (https=)
AU (1) AU2002325221B2 (https=)
BR (1) BR0210158A (https=)
CA (1) CA2448058C (https=)
DE (1) DE60219009T2 (https=)
DK (1) DK1401826T3 (https=)
ES (1) ES2282446T3 (https=)
GB (1) GB0113524D0 (https=)
MX (1) MXPA03011199A (https=)
PT (1) PT1401826E (https=)
WO (1) WO2002100853A1 (https=)
ZA (1) ZA200308781B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
US8022225B2 (en) 2004-08-04 2011-09-20 Taisho Pharmaceutical Co., Ltd Triazole derivative
WO2006072833A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
RU2409570C2 (ru) 2006-02-03 2011-01-20 Тайсо Фармасьютикал Ко., Лтд. Производные триазола
CN101415687B (zh) 2006-02-06 2012-02-08 大正制药株式会社 鞘氨醇-1-磷酸结合抑制物质
RU2451676C2 (ru) 2006-08-16 2012-05-27 Ф.Хоффманн-Ля Рош Аг Ненуклеозидные ингибиторы обратной транскриптазы
JP2010530863A (ja) 2007-06-22 2010-09-16 エフ.ホフマン−ラ ロシュ アーゲー 非ヌクレオシド逆転写酵素阻害剤としての尿素及びカルバマート誘導体
US8048898B2 (en) 2007-08-01 2011-11-01 Taisho Pharmaceutical Co., Ltd Inhibitor of binding of S1P1
WO2009080534A1 (en) 2007-12-21 2009-07-02 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
EP2295038B1 (en) * 2009-09-11 2013-05-29 AiCuris GmbH & Co. KG Solid dispersion comprising an anti-HIV agent
EP2571854B1 (en) * 2010-05-20 2014-11-05 Bayer Intellectual Property GmbH Method for manufacturing 1-alkyl-3-difluormethyl-5-hydroxypyrazoles
AU2011277426B2 (en) 2010-07-15 2015-04-23 Sumitomo Pharma Co., Ltd. Pyrazole compound
WO2014074628A1 (en) * 2012-11-08 2014-05-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compounds for treating hiv and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015060A1 (fr) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue et bactericide agrohorticole
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
DK0786455T3 (da) 1994-09-26 2004-03-29 Shionogi & Co Imidazolderivater
US5698495A (en) 1995-11-15 1997-12-16 Zeneca Limited Herbicidal substituted pyrazole compounds
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) * 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases

Also Published As

Publication number Publication date
CN1249052C (zh) 2006-04-05
CN1527829A (zh) 2004-09-08
ATE357439T1 (de) 2007-04-15
GB0113524D0 (en) 2001-07-25
JP2004532276A (ja) 2004-10-21
BR0210158A (pt) 2004-06-08
KR20040003050A (ko) 2004-01-07
EP1401826B1 (en) 2007-03-21
DE60219009D1 (de) 2007-05-03
DE60219009T2 (de) 2007-12-13
ZA200308781B (en) 2005-02-11
CA2448058C (en) 2008-12-23
DK1401826T3 (da) 2007-07-30
JP4088249B2 (ja) 2008-05-21
US6538015B1 (en) 2003-03-25
CA2448058A1 (en) 2002-12-19
MXPA03011199A (es) 2004-02-26
AU2002325221B2 (en) 2008-07-31
KR100627532B1 (ko) 2006-09-21
WO2002100853A1 (en) 2002-12-19
PT1401826E (pt) 2007-06-19
EP1401826A1 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
ES2282446T3 (es) Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih).
KR101139314B1 (ko) 피리미도티오펜 화합물
BR112020008850A2 (pt) composto, composição farmacêutica e método para tratar uma doença mediada por jak1 e jak3
ES2291854T3 (es) Inhibidores no nucleosidos de la transcriptasa inversa.
TW200831491A (en) N-aryl pyrazole compounds, compositions, and methods for their use
US12227482B2 (en) Compounds and compositions for the treatment of cancer
CA2816769A1 (en) Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
PT1024138E (pt) Derivados de pirazole
AU2002325221A1 (en) Pyrazole Derivatives as HIV Reverse Transcriptase Inhibitors
MXPA04008807A (es) Derivados de 4-(imidazol-5-il)-2-(4-sulfonilanilino)pirimidina con actividad inhibidora de cdk.
US6737429B2 (en) Pyrrole derivatives
AU2001263874A1 (en) Pyrrole derivatives for treating aids
ES2251529T3 (es) Derivados de imidazol para el tratamiento den efermedades viricas.
JP4772034B2 (ja) 抗ウイルス性4−アミノカルボニルアミノ−置換イミダゾール化合物
HK40108482A (en) Compounds and compositions for the treatment of cancer
JP2005515171A (ja) 5−ヘテロ原子含有ピラゾールの効率的な合成法